Pricing Log in Create free account
Saturday 17 October 2026 Export COSM’s income statement to Excel — free account

Cosmos Health Inc.

COSM Healthcare Medical Distribution

Cosmos Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.3 million, up 19.9% from fiscal 2024. In the quarter to June 2026, revenue grew 28.8%, EPS was flat, free cash flow grew 9.39% and total debt rose 15.3%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

0.33 0.01 −2.94%
Market cap
$33.9M
P/E
0.0×
Fwd P/E
25.1×
Dividend yield
—
F-score
5/9
Altman Z
−2.50
Beneish M
−3.25
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 1.74
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy 5 2 7 2 — — — 3 2 — — —
Sell — — — — — — — — — — — —
Insider Ownership 53.44%

Capital & Financial Ratios $m

Market Cap 33.85
Revenue 73.73
Net Income (24.39)
Free Cash Flow (12.45)
Net Debt 9.30
Current Ratio 1.05
Debt/Equity 0.57
P/E ratio 0.00
Fwd P/E 25.10
P/S ratio 0.27
P/B ratio 0.96
Past 5Y EPS Growth —
This Y EPS Growth 65.08% (at or above 15%: strong)
Next Y EPS Growth 131.82% (at or above 15%: strong)
Next Y revenue growth 23.79% (at or above 10%: strong)
Next 5Y EPS Growth 62.88% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.4×, against a ten-year median of 0.3×; over the ten years it ranged from −0.1× in 2023 to 0.8× in 2023.
P/S against its own 10 years 80.70%
10-year low 10-year high
P/B against its own 10 years 88.59%
10-year low 10-year high
EV/Sales against its own 10 years 74.02%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 4 0 4 2
Receivables 21 15 22 21
Inventory 5 4 6 5
Other — — — —
37 25 38 37
2023 2024 2025 Q'26
Payables 12 12 17 14
ST’ Debt 7 7 9 9
Other 3 3 7 7
24 26 38 35

Compound Annual Growth %

10y 5y 3y
Sales — 3.33% 9.04%
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% (22.31%)

Revenue $m

Mar Jun Sep Dec Year
’26 18 19 — — —
’25 14 15 17 20 65
’24 15 13 12 14 54
’23 12 12 13 16 53
’22 13 13 12 12 50
’21 12 15 14 16 56
’20 12 13 14 16 55
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (1) (2) — — —
’25 0 (1) (2) (5) (8)
’24 (3) (1) 1 (4) (8)
’23 (6) (6) (5) 1 (16)
’22 (2) (1) (2) (10) (15)
’21 (1) (2) (3) (2) (7)
’20 (1) (5) (4) (1) (12)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (2) (1) — — —
’25 0 (1) (3) (6) (11)
’24 (3) (1) 1 (5) (9)
’23 (6) (9) (7) (3) (25)
’22 (2) (1) (2) (10) (15)
’21 (1) (2) (4) (2) (8)
’20 (1) (5) (4) (1) (12)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.06) (0.10) — — —
’25 (0.03) (0.10) (0.17) (0.31) (0.63)
’24 (0.11) (0.15) (0.45) (0.45) (1.17)
’23 (0.04) (0.09) (0.27) (1.73) (2.15)
’22 (7.75) (23.25) (2.00) (3.96) (33.16)
’21 (3.61) (3.69) (2.83) (1.99) (12.12)
’20 (0.91) 2.60 1.43 (1.57) 1.54
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 3.20 4.01 2.11 2.03 1.15 2.13 0.07 0.97 0.47 0.28

Analyst estimates 2026–2028

Powerpack
High 8.20 10.65 12.50 4.00 5.65 7.77 23.84 7.44 1.58 1.32
People
People Employees — 1 1 68 85 95 102 123 149 163
Revenue/emp, $m 0.00 30.01 37.08 0.58 0.65 0.59 0.49 0.43 0.37 0.40
Income, $m
Income, $m Revenue 7 30 37 40 55 56 50 53 54 65
Gross margin, % 8.90 6.52 6.50 9.23 14.55 14.81 11.83 8.15 7.92 12.10
EBT (1) (6) (9) (3) 1 (8) (13) (19) (16) (19)
EBT margin, % (8.88) (20.68) (24.39) (7.85) 2.16 (13.95) (25.93) (34.74) (29.73) (29.33)
Net income (1) (6) (9) (3) 1 (8) (14) (19) (16) (19)
Depreciation 0 1 6 1 0 1 2 1 1 1
Per share, $
Per share, $ Revenue 13.44 58.71 69.67 74.73 104.38 85.61 26.11 4.46 2.84 2.16
Earnings (1.20) (12.15) (17.02) (6.21) 1.55 (11.42) (33.16) (2.15) (1.17) (0.63)
Cash flow (4.23) (17.14) (2.92) (9.02) (21.67) (10.80) (7.71) (1.31) (0.40) (0.28)
Capex (0.03) (0.11) (0.95) (1.27) (0.22) (1.36) (0.19) (0.77) (0.07) (0.07)
Free cash flow (4.26) (17.24) (3.87) (10.29) (21.89) (12.16) (7.90) (2.07) (0.47) (0.35)
Book value (3.49) (5.92) (6.23) (12.17) (7.84) 6.67 20.37 3.01 1.28 0.61
Shares, m 1 1 1 1 1 1 2 12 19 30
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 3.30 0.00 0.00 0.00 0.00 0.00
P/S 0.61 0.18 0.06 0.03 0.05 0.04 0.21 0.31 0.24 0.23
P/B 0.00 0.00 0.00 0.00 0.00 0.51 0.27 0.45 0.52 0.82
EV/Sales 0.53 0.16 0.09 0.16 0.38 0.42 0.00 0.42 0.39 0.41
EV/FCF (1.67) (0.54) (1.65) (1.15) (1.81) (3.04) (0.01) (0.90) (2.34) (2.52)
Cash, $m
Cash, $m Operating cash flow (2) (9) (2) (5) (12) (7) (15) (16) (8) (8)
Capex 0 0 (1) (1) 0 (1) 0 (9) (1) (2)
Free cash flow (2) (9) (2) (5) (12) (8) (15) (25) (9) (11)
Balance, $m
Balance, $m Working capital (2) (4) (4) (7) 6 10 35 12 0 0
Total debt 0 0 5 5 19 21 10 10 9 15
Net debt (1) (1) 1 5 18 21 (11) 6 8 12
Shareholders’ equity (2) (3) (3) (6) (4) 4 39 36 25 18
Returns, %
Returns, % ROA (8.71) (90.03) (57.77) (14.80) 2.42 (33.44) (108.87) (38.47) (37.20) (31.96)
ROIC 0.00 0.00 0.00 0.00 11.94 (11.11) (16.26) (32.58) (29.66) (34.86)
ROE 25.14 259.79 285.59 67.48 (15.46) (14,274.32) (292.90) (68.46) (73.88) (89.13)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Cosmos Health Inc. vs peers in Medical Distribution (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
CAH Cardinal Health, Inc. $58.8B 35.0× 23.3× +5.84% (above 0%: growing) +68.32% (above 0%: growing) +10.87% (above 0%: growing) 4.02% 1.14% Compare
HSIC Henry Schein, Inc. $9.7B 25.0× 18.5× +6.73% (above 0%: growing) +16.90% (above 0%: growing) +140.91% (above 0%: growing) 31.84% 4.95% Compare
AHG Akso Health Group Sponsored ADR $1.2B — (loss-making) — (loss-making) +263.89% (above 0%: growing) n/m −12,975.04% (below 0%: shrinking) 0.00% 0.00% Compare
FOCL FocalTherics $154.8M — (loss-making) — (loss-making) +38.85% (above 0%: growing) n/m +21.49% (above 0%: growing) 55.59% (60.83%) Compare
COSM Cosmos Health Inc. $33.9M — (loss-making) 25.1× +28.76% (above 0%: growing) n/m +9.39% (above 0%: growing) 7.96% (15.41%)
ACH Accendra Health, Inc. $20.1M — (loss-making) — (loss-making) −10.07% (below 0%: shrinking) n/m −1,624.82% (below 0%: shrinking) 42.95% (5.73%) Compare
HKPD Cellyan Biotechnology Co., Ltd $17.1M — — — — −90.45% (below 0%: shrinking) — — Compare
YI 111, Inc. Sponsored ADR $16.0M — (loss-making) — (loss-making) −29.61% (below 0%: shrinking) n/m −185.70% (below 0%: shrinking) 5.33% (0.85%) Compare
SNYRQ Synergy CHC Corp. $1.3M — (loss-making) 1.6× −32.77% (below 0%: shrinking) n/m −148.51% (below 0%: shrinking) 72.29% (10.32%) Compare
Median of peers $87.5M — 18.5× +5.84% — −119.48% 31.84% (0.85%)

All 11 Medical Distribution stocks →

Cosmos Health Inc. (COSM) key facts

  • Strength: Cosmos Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.3 million, up 19.9% from fiscal 2024.
  • Cosmos Health Inc. (COSM) is a Medical Distribution company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, COSM traded at $0.33, a market capitalization of $33.9 million.
  • Return on equity was −89.1% and debt-to-equity 0.57.
  • Its Piotroski F-score is 5 out of 9 and its Altman Z-score is −2.50 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Cosmos Health Inc. (COSM) Latest News

15 Apr

Impact 5 ·
Impact 5 ·

11 Oct

Impact 5 ·
stockrow.com/COSM · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com